A. Druskis Lab - Company finances
|
EUR
|
2020
From: 2020-02-25
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 27,665 | 69,832 | 107,897 | 107,273 | 83,095 | 90,351 |
| Profit before tax | 14,289 | 26,332 | 33,953 | 33,957 | 1,759 | 604 |
| Net profit | 14,289 | 25,015 | 32,188 | 31,696 | 1,073 | 212 |
| Equity | 14,389 | 39,404 | 71,592 | 100,488 | 101,561 | 88,473 |
| Liabilities | - | - | 2,496 | 34,841 | 25,921 | 18,442 |
| Non-current assets | 0 | 9,857 | 10,348 | 68,429 | 58,284 | 47,525 |
| Current assets | 14,779 | 30,881 | 63,740 | 66,900 | 69,198 | 59,390 |
| Total assets | 14,779 | 40,738 | 74,088 | 135,329 | 127,482 | 106,915 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 4,516 | 5,245 | 1,315 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | +152.4% | +54.5% | -0.6% | -22.5% | +8.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 96.7% | 61.4% | 43.4% | 23.4% | 0.8% | 0.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 99.3% | 63.5% | 45.0% | 31.5% | 1.1% | 0.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 51.7% | 35.8% | 29.8% | 29.5% | 1.3% | 0.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 51.7% | 37.7% | 31.5% | 31.7% | 2.1% | 0.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 0.0 | 0.3 | 0.3 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | 107,897 | - | 83,095 | 90,351 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
A. Druskis Lab - Social security debts
The company had no debts to Sodra
A. Druskis Lab - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
A. Druskis Lab, MB (code 305481672) is a Lithuanian small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the latest financial year, the company generated revenue of €90.4K, up 8.7% year on year, but still 15.8% below the level two years earlier. Profitability remained very limited: net profit was €212, after €1.1K in 2024 and €31.7K in 2023, showing a clear downward trajectory despite the revenue recovery. The 2025 profit margin was 0.2%, while return on equity and return on assets were also at 0.2%, reflecting the very small earnings base. The balance sheet was relatively conservative, with total assets of €106.9K, equity of €88.5K and liabilities of €18.4K. The equity ratio stood at 82.8% and debt-to-equity at 0.21, indicating low leverage. Asset turnover was 0.85x. With no staff figures beyond revenue per employee, productivity in 2025 was €90.4K of revenue and €212 of profit per employee.